Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31919
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMotaganahalli, S-
dc.contributor.authorBatrouney, A-
dc.contributor.authorPerera, Dhineli-
dc.contributor.authorVogrin, S-
dc.contributor.authorTrubiano, Jason-
dc.date.accessioned2023-01-12T05:14:28Z-
dc.date.available2023-01-12T05:14:28Z-
dc.date.issued2022-12-23-
dc.identifier.citationThe Journal of Antimicrobial Chemotherapy 2022; 78(1): 284-288en_US
dc.identifier.issn1460-2091-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/31919-
dc.description.abstractOptimal treatment duration for residual osteomyelitis (OM) post-amputation in diabetic foot infection (DFI) remains unclear, with resultant heterogeneity in prescribing noted in clinical practice. We aimed to identify a difference in outcomes of long duration of antibiotics (LD) with short duration (SD) in patients with culture-positive proximal bone specimen post-amputation.en_US
dc.language.isoeng-
dc.titleRetrospective study of outcomes of short versus long duration of antibiotic therapy for residual osteomyelitis in surgically resected diabetic foot infection.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleThe Journal of Antimicrobial Chemotherapyen_US
dc.identifier.affiliationInfectious Diseasesen_US
dc.identifier.affiliationPharmacyen_US
dc.identifier.affiliationMedicine (University of Melbourne)en_US
dc.identifier.doi10.1093/jac/dkac390en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-6739-0424en_US
dc.identifier.pubmedid36418157-
dc.description.volume78-
dc.description.issue1-
dc.description.startpage284-
dc.description.endpage288-
dc.subject.meshtermssecondaryDiabetic Foot/complications-
dc.subject.meshtermssecondaryDiabetic Foot/drug therapy-
dc.subject.meshtermssecondaryDiabetic Foot/surgery-
dc.subject.meshtermssecondaryOsteomyelitis/drug therapy-
dc.subject.meshtermssecondaryOsteomyelitis/surgery-
dc.subject.meshtermssecondaryAnti-Bacterial Agents/therapeutic use-
dc.subject.meshtermssecondaryCommunicable Diseases/drug therapy-
local.name.researcherPerera, Dhineli-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.deptPharmacy-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptCentre for Antibiotic Allergy and Research-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

68
checked on Oct 4, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.